Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A known ✓ | P08908 | 14/20 | 0.98 |
| ▸ | ADRA1A known ✓ | P35348 | 7/20 | 0.98 |
| ▸ | DRD4 known ✓ | P21917 | 6/20 | 0.77 |
| ▸ | ADRA1B known ✓ | P35368 | 6/20 | 0.77 |
| ▸ | ADRA1D known ✓ | P25100 | 4/20 | 0.77 |
| ▸ | HTR2B known ✓ | P41595 | 3/20 | 0.77 |
| ▸ | HTR7 known ✓ | P34969 | 4/20 | 0.75 |
| ▸ | HTR1B known ✓ | P28222 | 2/20 | 0.75 |
| ▸ | HTR2A known ✓ | P28223 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8013725 | 0.99 | HTR1A (1.00) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| SCHEMBL16709203 | 0.88 | HTR1A (0.80) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| SCHEMBL15722844 | 0.88 | HTR1A (0.80) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| SCHEMBL14821959 | 0.88 | HTR1A (0.80) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| SCHEMBL15709818 | 0.88 | HTR1A (0.80) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| SCHEMBL15722864 | 0.88 | HTR1A (0.80) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| Way-100,635 SCHEMBL6064589 | 0.87 | HTR1A (1.00) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| Way-100,635 SCHEMBL2877337 | 0.87 | HTR1A (1.00) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| Way-100,635 SCHEMBL29486911 | 0.87 | HTR1A (1.00) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B | |
| SCHEMBL7956950 | 0.87 | HTR1A (0.78) | HTR1AADRA1ASMN1; SMN2DRD4ADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098092-A1 | MONOCLONAL ANTIBODIES AGAINST HUMAN PROGRAMMED CELL DEATH PROTEIN 1 (PD-1) | CHULALONGKORN UNIV (TH) | 2026-04-09 | — | — | US | disclosed |
| US-12498926-B1 | Microprocessor that builds consistent loop iteration count unrolled loop multi-fetch block macro-op cache entries | Ventana Micro Systems Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12498928-B1 | Microprocessor that builds multi-fetch block macro-op cache entries in two-stage process | Ventana Micro Systems Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12498933-B1 | Prediction unit that predicts successor fetch block start address of multi-fetch block macro-op cache entry | Ventana Micro Systems Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12498927-B1 | Microprocessor that allows same-fetch block start address co-residence of unrolled loop multi-fetch block macro-op cache entry and loop body macro-op cache entry used to build same | Ventana Micro Systems Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12498929-B1 | Microprocessor that performs partial fallback abort processing of multi-fetch block macro-op cache entries | Ventana Micro Systems Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12493466-B1 | Microprocessor that builds inconsistent loop that iteration count unrolled loop multi-fetch block macro-op cache entries | Ventana Micro Systems Inc. (US) | 2025-12-09 | — | — | US | disclosed |
| US-12493469-B1 | Microprocessor that extends sequential multi-fetch block macro-op cache entries | Ventana Micro Systems Inc. (US) | 2025-12-09 | — | — | US | disclosed |
| US-12493468-B1 | Microprocessor that performs mid-macro-op cache entry restart abort processing | Ventana Micro Systems Inc. (US) | 2025-12-09 | — | — | US | disclosed |
| US-12487926-B1 | Prediction unit that predicts branch history update information produced by multi-fetch block macro-op cache entry | Ventana Micro Systems Inc. (US) | 2025-12-02 | — | — | US | disclosed |
| US-20230401065-A1 | BRANCH TARGET BUFFER THAT STORES PREDICTED SET INDEX AND PREDICTED WAY NUMBER OF INSTRUCTION CACHE | Ventana Micro Systems Inc. | 2023-12-14 | — | — | US | disclosed |
| US-20230401066-A1 | DYNAMICALLY FOLDABLE AND UNFOLDABLE INSTRUCTION FETCH PIPELINE | Ventana Micro Systems Inc. | 2023-12-14 | — | — | US | disclosed |
| US-11836498-B1 | Single cycle predictor | Ventana Micro Systems Inc. (US) | 2023-12-05 | — | — | US | disclosed |
| US-11816489-B1 | Microprocessor with prediction unit pipeline that provides a next fetch address at a rate of one per clock cycle | Ventana Micro Systems Inc. (US) | 2023-11-14 | — | — | US | disclosed |
| CN-116949627-A | Regenerated polyester coated yarn preparation device | 苏州汇力高纤有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20230243811-A1 | IDENTIFICATION OF TRANSPLANTED HUMAN CELLS | RIGSHOSPITALET (REGH) (DK) | 2023-08-03 | — | — | US | disclosed |
| US-11712487-B2 | Composite embolization beads | RAIKA MEDICAL IMAGING INC. (US) | 2023-08-01 | — | — | US | disclosed |
| CN-115380035-A | Novel quinazoline compounds as therapeutic agents for metabolic disorders | (株式会社)生命程道 | 2022-11-22 | — | — | CN | disclosed |
| EP-4087654-A1 | TREATMENT OF ALZHEIMER'S DISEASE | Selonterra, Inc. (US) | 2022-11-16 | — | — | EP | disclosed |
| US-20220358048-A1 | VIRTUALLY-INDEXED CACHE COHERENCY USING PHYSICAL ADDRESS PROXIES | Ventana Micro Systems Inc. | 2022-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098092-A1 | MONOCLONAL ANTIBODIES AGAINST HUMAN PROGRAMMED CELL DEATH PROTEIN 1 (PD-1) | IGSF11, CD274, PDCD1LG2 | HTR1A 2906/4885ADRA1A 2910/4885DRD4 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.